Next-Gen Therapies for AMD and DME

Nicole Eter, MD

Show Description +

Dr. Eter details the robust therapeutic pipeline for AMD and DME, providing insights into the future of our treatment paradigms.

Posted: 10/01/2024

Keywords:

retina-meeting-recap

•

pipeline

•

Age-Related Macular Degeneration (AMD)

•

Diabetic macular edema, DME

•

REGENXBIO

•

RGX-314

•

Geographic Atrophy (GA)

•

Anti-VEGF

•

biosimilars

•

Bevacizumab

•

prefilled syringe

•

faricimab

•

Eylea

•

Ranibizumab

•

FDA Approval/Clearance

•

Clinical Trials

•

dutafab

•

tyrosine kinase inhibitors

•

vorolinib

•

Gene Therapy

•

Ixo-vec

•

areds

•

complement inhibition

•

complement

•

Pegcetacoplan

•

macrophage

•

Imported Tags > Retinal Pigment Epithelium (RPE)

Up Next

Name: Next-Gen Therapies for AMD and DME
Uploaded: 2024-10-01T22:16:16+00:00
Description: Dr. Eter details the robust therapeutic pipeline for AMD and DME, providing insights into the future of our treatment paradigms.

The Role of Anti-VEGF Therapy in Diabetic Vitreous Hemorrhage

David Steel, MD, MBBS, FRCOphth

Exploring VEGF-C and -D Inhibition

Timothy L. Jackson, PhD, MB ChB, FRCOphth

The Clinical Benefits of the PDS

Patricia Udaondo, MD

RD Repair: Why Slower Reattachment is Better

Stratos V. Gotzaridis, MBBS, MD

Today's Approaches to Myopic Neovascularization

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

Anti-VEGF for ROP: Efficacy and Safety Outcomes

Andreas Stahl, MD

Advancing Research Methodology in Retina

Varun Chaudhary, MD, FRCS(C)

The Clinical Challenges of AAV Vectors

Kanmin Xue, PhD, MA, MB, BChir, FRCOphth

Plasma Kallikrein Inhibition: A Novel Approach to DME

Arshad Khanani, MD, MA, FASRS

Back to All Videos

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

Dr. Eter details the robust therapeutic pipeline for AMD and DME, providing insights into the future of our treatment paradigms.

Posted: 10/01/2024

Keywords:

retina-meeting-recap

•

pipeline

•

Age-Related Macular Degeneration (AMD)

•

Diabetic macular edema, DME

•

REGENXBIO

•

RGX-314

•

Geographic Atrophy (GA)

•

Anti-VEGF

•

biosimilars

•

Bevacizumab

•

prefilled syringe

•

faricimab

•

Eylea

•

Ranibizumab

•

FDA Approval/Clearance

•

Clinical Trials

•

dutafab

•

tyrosine kinase inhibitors

•

vorolinib

•

Gene Therapy

•

Ixo-vec

•

areds

•

complement inhibition

•

complement

•

Pegcetacoplan

•

macrophage

•

Imported Tags > Retinal Pigment Epithelium (RPE)

Please log in to leave a comment.

Meeting Coverage:

EURETINA Congress

Next-Gen Therapies for AMD and DME

Up Next

Next-Gen Therapies for AMD and DME

More From EURETINA: 2024 Coverage